Unconventional ligand activation of herpesvirus entry mediator signals cell survival (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 15, (6244-6249) DOI: 10.1073/pnas.0902115106));Unconventional ligand activation of herpesvirus entry mediator signals cell survival

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 15, 2009, Pages 6244-6249

  Cheung, Timothy C ^a,e   Steinberg, Marcos W ^a   Oborne, Lisa M ^a   Macauley, Matthew G ^a   Fukuyama, Satoshi ^a   Sanjo, Hideki ^a   D'Souza, Claire ^a   Norris, Paula S ^a   Pfeffer, Klaus ^b   Murphy, Kenneth M ^c   Kronenberg, Mitchell ^a   Spear, Patricia G ^d   Ware, Carl F ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; CD 160; GLYCOPROTEIN D; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; BTLA PROTEIN, HUMAN; CD160 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; EPITHELIUM TUMOR; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LYMPHOID CELL; MUCOSA; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR CELL LINE; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

HERPESVIRIDAE; SIMPLEXVIRUS;

ANIMALS; ANTIGENS, CD; CELL LINE; CELL SURVIVAL; HUMANS; IMMUNOGLOBULINS; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTOR RELA; VIRAL ENVELOPE PROTEINS;

EID: 65549083845     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0909295106     Document Type: Erratum

References (35)

1. Montgomery RI, Warner MS, Lum B, Spear PG (1996) Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
2. Mauri DN, et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30.
3. Gommerman JL, Browning JL (2003) Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 3:642-655.
4. Ware CF (2008) Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223:186-201.
5. Sedy JR, et al. (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6:90-98.
6. Gonzalez LC, et al. (2005) A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci USA 102:1116-1121.
7. Cai G, et al. (2008) CD160 inhibits activation of human CD4-T cells through interaction with herpesvirus entry mediator. Nat Immunol 9:176-185.
8. Murphy KM, Nelson CA, Sedy JR (2006) Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 6:671-681.
9. Hsu H, et al. (1997) ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem 272:13471-13474.
10. Rooney IA, et al. (2000) The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 275:14307-14315.
11. Watanabe N, et al. (2003) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4:670-679.
12. Chemnitz JM, Lanfranco AR, Braunstein I, Riley JL (2006) B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J Immunol 176:6603-6614.
13. Nelson CA, et al. (2008) Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J Immunol 180:940-947.
14. Compaan DM, Hymowitz SG (2006) The crystal structure of the costimulatory OX40-OX40L complex. Structure 14:1321-1330.
15. Carfi A, et al. (2001) Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell 8:169-179.
16. Compaan DM, et al. (2005) Attenuating lymphocyte activity: The crystal structure of the BTLA-HVEM complex. J Biol Chem 280:39553-39561.
17. Cheung TC, et al. (2005) Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA 102:13218-13223.
18. Watts TH, Gommerman JL (2005) The LIGHT and DARC sides of herpesvirus entry mediator. Proc Natl Acad Sci USA 102:13365-13366.
19. Wang Y, et al. (2005) The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115:711-717.
20. Krieg C, Han P, Stone R, Goularte OD, Kaye J (2005) Functional analysis of B and T lymphocyte attenuator engagement on CD4-and CD8-T cells. J Immunol 175:6420-6427.
21. Steinberg MW, et al. (2008) A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med 205:1463-1476.
22. Hurchla MA, Sedy JR, Murphy KM (2007) Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J Immunol 178:6073-6082.
23. Anumanthan A, et al. (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161:2780-2790.
24. Gavrieli M, Sedy J, Nelson CA, Murphy KM (2006) BTLA and HVEM cross talk regulates inhibition and costimulation. Adv Immunol 92:157-185.
25. Kaye J (2008) CD160 and BTLA: LIGHTs out for CD4- T cells. Nat Immunol 9:122-124.
26. Bodmer JL, Schneider P, Tschopp J (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27:19-26.
27. Handler CG, Eisenberg RJ, Cohen GH (1996) Oligomeric structure of glycoproteins in herpes simplex virus type 1. J Virol 70:6067-6070.
28. Giustiniani J, Bensussan A, Marie-Cardine A (2009) Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 182:63-71.
29. Croft M (2003) Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immunol 3:609-620.
30. Song J, So T, Cheng M, Tang X, Croft M (2005) Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22:621-631.
31. De Trez C, et al. (2008) The inhibitory HVEM-BTLA pathway counter regulates lym-photoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol 180:238-248.
32. Sciortino MT, et al. (2008) Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD. Biochem Pharmacol 76:1522-1532.
33. Sedy JR, Spear PG, Ware CF (2008) Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8:861-873.
34. Van Arsdale TL, et al. (1997) Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor β B. Proc Natl Acad Sci USA 94:2460-2465.
35. Cheung TC, Hearn JP (2005) Dimerizations of the wallaby gonadotropin-releasing hormone receptor and its splice variants. Gen Comp Endocrinol 144:280-288.